ECL

ACCO Brands Corporation Announces Appointment of Beth Simermeyer to Board of Directors

Retrieved on: 
Thursday, December 7, 2023

ACCO Brands Corporation (NYSE: ACCO) today announced that Beth Simermeyer has been elected to the Board of Directors, effective December 5, 2023.

Key Points: 
  • ACCO Brands Corporation (NYSE: ACCO) today announced that Beth Simermeyer has been elected to the Board of Directors, effective December 5, 2023.
  • “We are excited to welcome Beth, a dynamic business leader with a proven track record of success to ACCO Brands’ Board of Directors.
  • Beth’s extensive marketing expertise, P&L ownership and global leadership mindset, will further enhance our Board and help us execute on our strategic transformation.
  • We look forward to leveraging Beth’s insights to continue to further strengthen the company going forward,” said Boris Elisman, Executive Chairman of ACCO Brands Corporation.

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Retrieved on: 
Tuesday, October 17, 2023

MUMBAI, India, Oct. 17, 2023 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions (PPS) business, a leading Contract Development and Manufacturing Organization (CDMO), today formally announced the launch of a world-class high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India.

Key Points: 
  • MUMBAI, India, Oct. 17, 2023 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions (PPS) business, a leading Contract Development and Manufacturing Organization (CDMO), today formally announced the launch of a world-class high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India.
  • This new expansion significantly adds primary and secondary screening capabilities of compounds prepared at the Ahmedabad site.
  • With this expansion, Piramal Pharma Solutions is uniquely positioned to provide clients with an integrated set of discovery capabilities and leverage a wide range of in-vitro screening technology tools to support its broad portfolio of research services.
  • Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions said, "Through these enhanced in-vitro biology services, our drug discovery team will be able to provide clients with decision-driving information earlier and will be an even more effective partner in the drug discovery process."

Jericho Energy Ventures Inc.: The Policy Power of Renewable Tech Advancements

Retrieved on: 
Tuesday, September 26, 2023

Jericho Energy Ventures Inc. (TSXV: JEV) (OTC: JROOF), Ecolab Inc. (NYSE: ECL), Enphase Energy, Inc. (NASDAQ: ENPH), and Tesla, Inc. (NASDAQ: TSLA) are companies harnessing today's technological innovations.

Key Points: 
  • Jericho Energy Ventures Inc. (TSXV: JEV) (OTC: JROOF), Ecolab Inc. (NYSE: ECL), Enphase Energy, Inc. (NASDAQ: ENPH), and Tesla, Inc. (NASDAQ: TSLA) are companies harnessing today's technological innovations.
  • Jericho Energy Ventures (TSXV: JEV) (OTC: JROOF) is an energy company positioned for the current energy transitions.
  • Jericho co-led a Series A investment in H2U along with Dolby Family Ventures, Hess Corporation (NYSE: HES), and Motus Ventures, and has an appointee to H2U’s Board of Directors.
  • Meanwhile, Jericho Energy Ventures' portfolio company's non-iridium catalysts offer a six-year lifespan in specific uses like PEM electrolyzers, marking a commercial breakthrough.

Fifth Third Bank Certifies 25 Graduates of its Empowering Community Leaders Program

Retrieved on: 
Tuesday, September 5, 2023

Fifth Third congratulates the 25 community leaders who have completed the Bank’s 18-month Empowering Community Leaders career development growth program.

Key Points: 
  • Fifth Third congratulates the 25 community leaders who have completed the Bank’s 18-month Empowering Community Leaders career development growth program.
  • View the full release here: https://www.businesswire.com/news/home/20230905801694/en/
    The inaugural class of 25 nonprofit leaders graduated from Fifth Third Bank's Empowering Community Leaders program.
  • The 25 graduates are pictured with Fifth Third's Aleta Young, Kala Gibson, Jada Grandy Mock and Katrina Lunsford, pictured from left to right, in the first row.
  • She said, “Fifth Third presented me with such an awesome opportunity to better equip myself to serve my community.

Emerald Cloud Lab Makes Programming Language for Conducting Remote Scientific Experiments Open Source

Retrieved on: 
Tuesday, August 22, 2023

AUSTIN, Texas, Aug. 22, 2023 /PRNewswire/ -- Emerald Cloud Lab (ECL), the first and leading highly automated cloud laboratory, today announced the company's proprietary Symbolic Lab Language (SLL) will now be open source for research use. This will allow scientists and entrepreneurs from around the world to utilize the industry's most robust and established programming language for remotely conducting scientific experiments in a cloud lab and build upon it to help foster an open science ecosystem. 

Key Points: 
  • The world's largest cloud lab provides open access to its previously proprietary Symbolic Lab Language (SLL), allowing researchers to leverage the most widely used computational language for remotely conducting scientific experiments.
  • AUSTIN, Texas, Aug. 22, 2023 /PRNewswire/ -- Emerald Cloud Lab (ECL), the first and leading highly automated cloud laboratory , today announced the company's proprietary Symbolic Lab Language (SLL) will now be open source for research use.
  • This will allow scientists and entrepreneurs from around the world to utilize the industry's most robust and established programming language for remotely conducting scientific experiments in a cloud lab and build upon it to help foster an open science ecosystem.
  • SLL is generally considered the most developed and widely used language for remotely controlling experiments in a cloud lab.

Clairvest Reports Fiscal 2024 First Quarter Results

Retrieved on: 
Thursday, August 10, 2023

TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2024 first quarter ended June 30, 2023 and events which occurred subsequent to quarter end.

Key Points: 
  • TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2024 first quarter ended June 30, 2023 and events which occurred subsequent to quarter end.
  • On closing of the acquisition, Clairvest and CEP VI invested US$25.2 million in New Hampshire Gaming in addition to US$24.5 million which had been previously funded.
  • For Clairvest, it invested US$6.8 million (C$9.2 million) in addition to US$6.6 million (C$8.9 million) previously funded.
  • As at August 10, 2023, Clairvest completed the final closing of CEP VII at the US$1.2 billion hard cap, with commitments of US$900 million from third party investors and US$300 million from Clairvest.

EQS-News: Bank of Scotland plc: 2023 Half-Year Results

Retrieved on: 
Wednesday, July 26, 2023

Bank of Scotland plc (the Bank) and its subsidiaries (together, the Group) provide a wide range of banking and financial services.

Key Points: 
  • Bank of Scotland plc (the Bank) and its subsidiaries (together, the Group) provide a wide range of banking and financial services.
  • Loss after tax was £31 million (half-year to 30 June 2022: profit after tax of £843 million).
  • Total income for the half-year to 30 June 2023 was £1,751 million, a decrease of 33 per cent on the first half of 2022.
  • Total equity increased by £234 million from £16,046 million at 31 December 2022 to £16,280 million at 30 June 2023.

Lloyds Bank plc: 2023 Half-Year Results

Retrieved on: 
Wednesday, July 26, 2023

Lloyds Bank plc (the Bank) and its subsidiary undertakings (the Group) provide a wide range of banking and financial services through branches and offices in the UK and in certain overseas locations.

Key Points: 
  • Lloyds Bank plc (the Bank) and its subsidiary undertakings (the Group) provide a wide range of banking and financial services through branches and offices in the UK and in certain overseas locations.
  • Other income was £68 million higher at £2,031 million in the half-year to 30 June 2023 compared to £1,963 million in the same period in 2022.
  • Total assets were £2,598 million lower at £614,330 million at 30 June 2023 compared to £616,928 million at 31 December 2022.
  • Strategic risk - The risk which results from:
    Click on, or paste the following link into your web browser, to view the associated PDF document.

Efficient Capital Labs raises $7 million Pre-Series A led by QED Investors to bridge the funding and cost gap for B2B SaaS businesses focusing on the South Asia-U.S. corridor.

Retrieved on: 
Thursday, July 13, 2023

ECL provides B2B SaaS companies a percentage of their ARR as upfront capital which is 100 percent non-dilutive in nature.

Key Points: 
  • ECL provides B2B SaaS companies a percentage of their ARR as upfront capital which is 100 percent non-dilutive in nature.
  • The latest round of funding led by QED Investors brings the total amount of capital raised by ECL to $110.5 million, which includes a $100 million debt facility.
  • This new round follows the equity raise in April last year of $3.5 million, led by 645 Ventures.
  • “Our value proposition is unmatched, we offer the most capital- and time-efficient solution for SaaS businesses looking to raise growth capital.

Clairvest Reports Fiscal 2023 Fourth Quarter and Year End Results

Retrieved on: 
Monday, June 26, 2023

TORONTO, June 26, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) today reported results for the fourth quarter and year ended March 31, 2023 and events which occurred subsequent to year end. (All figures are in Canadian dollars unless otherwise stated)

Key Points: 
  • TORONTO, June 26, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) today reported results for the fourth quarter and year ended March 31, 2023 and events which occurred subsequent to year end.
  • In aggregate, this represented 35% of our book value as at March 31, 2023, or approximately $28 per share.
  • Net loss for the fourth quarter was $13.8 million, or $0.92 per share.
  • The net income for the fourth quarter of fiscal 2023 reflects a net decrease in the fair value of Clairvest’s investee companies and a corresponding decrease in carried interest from the CEP Funds.